Noxopharm Ltd. (AU:NOX) has released an update.
Noxopharm Limited reports a significant reduction in its annual loss, down by 76.2% to $3,578,117 for the year ended 30 June 2024, compared to the previous year. The company also indicates no dividends were paid or declared during this period. Net tangible assets per share have decreased from 3.10 cents to 1.88 cents.
For further insights into AU:NOX stock, check out TipRanks’ Stock Analysis page.
